EPAS1 and neoplasm: It is interesting to note that whole exome sequencing (WES) analyses on both blood and tumor samples revealed a novel <i>EPAS1</i> mutation, specifically the c.2501A > G; p.Tyr834Cys variant, which has never been reported.